COVID-19 vaccines surveillance in France: a global response to a major national challenge

Anaesth Crit Care Pain Med. 2021 Jun;40(3):100866. doi: 10.1016/j.accpm.2021.100866. Epub 2021 Apr 22.

¹ French National Agency for Medicines and Health Products Safety, Surveillance Division, F- 93200 Saint-Denis, France. Electronic address: [email protected].
² Regional Pharmacovigilance Centre Lille, Clinical Pharmacology Department, U 1171 University Hospital of Lille, University of Lille, F-59000 Lille, France.
³ Regional Pharmacovigilance Centre, Clinical Pharmacology Department, Amiens-Picardie University Hospital, F-80054 Amiens, France.
⁴ Regional Pharmacovigilance Centre, Clinical Pharmacology Department, Rouen University Hospital, F-76031 Rouen, France.
⁵ Regional Pharmacovigilance Centre Marseille Provence Corse, Pharmacology & Pharmacovigilance Department, APHM, France; Aix Marseille University UMR INSERM 1106 Institut de Neurosciences des Systèmes, F-3274 Marseille, France.
⁶ Regional Pharmacovigilance Centre Franche Comté, Clinical Pharmacology Department, CHU de Besançon, F-25030 Besancon, France.

No abstract available

Keywords: SARS-CoV-2; pharmacovigilance; surveillance; vaccines.

Publication types